- Rating
- 2
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes PMRD, a multimodal framework for zero-shot drug property prediction using molecular structures, gene expression profiles, and cellular morphology. The method separates mechanism-consistent and modality-specific representations through cross-modal response modeling, and introduces stability-guided optimization to improve representation robustness. A reliability-aware retrieval strategy is further developed to combine predictions from multiple representation views. Experiments on ChEMBL2K and Broad6K demonstrate promising results compared with existing multimodal and zero-shot learning methods.
Critical strengths
The paper addresses an important problem in drug discovery. Integrating molecular structures with cellular responses is a meaningful direction for improving drug representation learning and property prediction.
Critical weaknesses
Top concern: Separating shared information from modality-specific variations during multimodal alignment has been explored in prior research. In particular, DECODE (Empowering Chemical Structures with Biological Insights for Scalable Phenotypic Virtual Screening, Bioinformatics, 2026) also integrates molecular structures, transcriptomic profiles, and cellular morphology, and explicitly separates shared and modality-specific representations through orthogonality constraints and contrastive alignment. The proposed MCR-MSR decomposition appears closely related to these existing techniques. However, the paper does not sufficiently discuss or compare with such related approaches. others:
-
The framework uses molecular structures, gene expression profiles, and cellular morphology for drug representation learning and prediction. However, it is unclear whether all three modalities are required for unseen drugs during inference. If transcriptomic and morphological measurements are necessary for every test compound, the method may have limited applicability to newly designed compounds without experimental profiling.
-
The proposed mechanism-consistent representations are mainly learned through representation separation, cross-modal alignment, contrastive learning, and stability regularization. However, these objectives do not necessarily ensure that the learned shared representations correspond to actual pharmacological mechanisms, since cross-modal correlations may also arise from experimental conditions or other confounding factors.
-
In Eq. (4), the proposed geometric reference penalizes high representation similarity between different drugs. However, drugs with different chemical structures may share targets or mechanisms of action and should potentially remain close in the learned representation space.
Questions for authors
Please see the critical weaknesses above